study_name	study_acronym	study_description	study_external_url	primary_investigator_name	primary_investigator_email	phs_accession	bioproject_accession	funding_agency	grant_id	organism_species	number_of_participants	number_of_samples	study_data_types	file_types_and_format	acl	study_access	study_version	type	program.program_acronym	data_access_level
LCCC 1108: Development of a Tumor Molecular Analyses Program and Its Use to Support Treatment Decisions (UNCseqTM)	LCCC 1108 (UNCseqTM)	"The primary objective of this specimen correlative study was two-fold: to provide a mechanism for the association of known molecular alterations with clinical outcomes, and to provide rapid genetic profiling of alterations with known clinical utility using tumor and germline specimens to support treatment decisions.

    Study Design:
        Prospective Longitudinal Cohort
    Study Type:
        Cohort
    Total number of consented subjects: 2074
    Subject Sample Telemetry Report (SSTR)"	https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001713	H. Shelton Ea+I1+J10647:K10647, H. Shelton Earp	hse@med.unc.edu	phs001713	PRJNA496300	NIH NCI	P30CA016086	Human	2074	3558	Genomic	FASTQ	['phs001713']	Controlled	phs001713.v1.p1	study	LCCC	Not specified in data
